Table 3.
Patterns of Prescription According to Drug Type and Presence/Absence of Contraindications
| Pillar | Prescribed | Possible to prescribe* | Possible to prescribe but not prescribed* |
|---|---|---|---|
| ACEi/ARB/ARNi | 208 (68.2) | 300 (98.4) | 96 (31.5) |
| β‐Blocker | 285 (93.4) | 284 (93.1) | 18 (5.9) |
| MRA | 99 (32.5) | 305 (100.0) | 206 (67.5) |
| SGLT2i | 14 (4.6) | 230 (75.4) | 217 (71.1) |
Data are given as number (percentage). Total patients (n=305). ACEi indicates angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin receptor–neprilysin inhibitor; MRA, mineralocorticoid receptor antagonist; and SGLT2i, sodium‐glucose cotransporter 2 inhibitor.
*
Prescriptibility based on the absence of contraindications.